Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Second Quarter 2016 Financial Results

Genmab published its Second Quarter 2016 financial results and held an investor conference call on August 9.  Click here to listen to the archived webcast. Click here to download the presentation slides. Click here to view the results. Click here to download the podcast.

nov 102016 Capital Markets Day

Genmab will host a Capital Markets Day on November 10, 2016 at the Four Seasons Hotel in New York. The meeting will feature a variety of Genmab speakers who will provide updates on our business including the clinical and pre-clinical pipelines, proprietary next generation antibody technologies and R&D capabilities. Click here for more information and to register for the event. This meeting will be webcast live and details on how to join the webcast will be available on


Lab tourVirtual Lab Tour

Watch our new virtual lab tour to learn more about Genmab’s research and development capabilities and our proprietary DuoBody® and HexaBody® technologies.